-
1
-
-
0036791678
-
Comparison of azithromycin and clarithromycin in triple therapy regimens for the eradication of Helicobacter pylori
-
Sullivan B, Coyle W, Nemec R, Dunteman T. Comparison of azithromycin and clarithromycin in triple therapy regimens for the eradication of Helicobacter pylori. Am J Gastroenterol 2002;97:2536-9.
-
(2002)
Am J Gastroenterol
, vol.97
, pp. 2536-2539
-
-
Sullivan, B.1
Coyle, W.2
Nemec, R.3
Dunteman, T.4
-
2
-
-
0034790520
-
Helicobacter pylori: Ulcers and more: The beginning of an era
-
Lacy BE, Rosemore J. Helicobacter pylori: ulcers and more: the beginning of an era. J Nutr 2001;131:2789S-93S.
-
(2001)
J Nutr
, vol.131
-
-
Lacy, B.E.1
Rosemore, J.2
-
3
-
-
0038235692
-
The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: The Canadian Adult Dyspepsia Empiric Treatment-Prompt Endoscopy (CADET-PE) study [Published correction appears in Aliment Pharmacol Ther 2004; 20:702]
-
Thomson AB, Barkun AN, Armstrong D, et al. The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment-Prompt Endoscopy (CADET-PE) study [Published correction appears in Aliment Pharmacol Ther 2004;20:702]. Aliment Pharmacol Ther 2003;17:1481-91.
-
(2003)
Aliment Pharmacol Ther
, vol.17
, pp. 1481-1491
-
-
Thomson, A.B.1
Barkun, A.N.2
Armstrong, D.3
-
4
-
-
0033807944
-
Recent developments in the epidemiology of Helicobacter pylori
-
Everhart JE. Recent developments in the epidemiology of Helicobacter pylori. Gastroenterol Clin North Am 2000;29: 559-78.
-
(2000)
Gastroenterol Clin North Am
, vol.29
, pp. 559-578
-
-
Everhart, J.E.1
-
5
-
-
0033664804
-
Helicobacter pylori infection in children: Recommendations for diagnosis and treatment
-
and North American Society for Pediatric Gastroenterology and Nutrition
-
Gold BD, Colletti RB, Abbott M, et al and North American Society for Pediatric Gastroenterology and Nutrition. Helicobacter pylori infection in children: recommendations for diagnosis and treatment. J Pediatr Gastroenterol Nutr 2000;31:490-7.
-
(2000)
J Pediatr Gastroenterol Nutr
, vol.31
, pp. 490-497
-
-
Gold, B.D.1
Colletti, R.B.2
Abbott, M.3
-
6
-
-
0029907820
-
A population-based serologic survey of Helicobacter pylori infection in children and adolescents in the United States
-
Staat MA, Kruszon-Moran D, McQuillan GM, Kaslow RA. A population-based serologic survey of Helicobacter pylori infection in children and adolescents in the United States. J Infect Dis 1996;174:1120-3.
-
(1996)
J Infect Dis
, vol.174
, pp. 1120-1123
-
-
Staat, M.A.1
Kruszon-Moran, D.2
McQuillan, G.M.3
Kaslow, R.A.4
-
7
-
-
0029816488
-
Pooled analysis of anti-Helicobacter pylori treatment regimens
-
Unge P, Berstad A. Pooled analysis of anti-Helicobacter pylori treatment regimens. Scand J Gastroentrol Suppl. 1996;220:27-40.
-
(1996)
Scand J Gastroentrol Suppl
, vol.220
, pp. 27-40
-
-
Unge, P.1
Berstad, A.2
-
9
-
-
7044247643
-
Will eradication of Helicobacter pylori infection influence the risk of gastric cancer?
-
Hunt RH. Will eradication of Helicobacter pylori infection influence the risk of gastric cancer? Am J Med 2004;117 (Suppl 5A):86S-91S.
-
(2004)
Am J Med
, vol.117
, Issue.SUPPL. 5A
-
-
Hunt, R.H.1
-
10
-
-
84921703317
-
H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer
-
Gisbert JP, Khorrami S, Carballo F, et al. H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer. Cochrane Database Syst Rev 2004;CD004062
-
(2004)
Cochrane Database Syst Rev
-
-
Gisbert, J.P.1
Khorrami, S.2
Carballo, F.3
-
11
-
-
4544263657
-
Eradication therapy in Helicobacter pylori positive peptic ulcer disease: Systematic review and economic analysis
-
Ford AC, Delaney BC, Forman D, Moayyedi P. Eradication therapy in Helicobacter pylori positive peptic ulcer disease: systematic review and economic analysis. Am J Gastroenterol 2004;99:1833-55.
-
(2004)
Am J Gastroenterol
, vol.99
, pp. 1833-1855
-
-
Ford, A.C.1
Delaney, B.C.2
Forman, D.3
Moayyedi, P.4
-
13
-
-
4043124586
-
Efficacy of the dosing regimen of pantoprazole 40 mg, amoxicillin 1000 mg and clarithromycin 500 mg, twice daily for 7 days, in the eradication of the Helicobacter pylori in patients with peptic ulcer
-
Coelho LGV, Mattos AA, Francisconi CFM, et al. Efficacy of the dosing regimen of pantoprazole 40 mg, amoxicillin 1000 mg and clarithromycin 500 mg, twice daily for 7 days, in the eradication of the Helicobacter pylori in patients with peptic ulcer. Arq Gastroenterol. 2004;41: 71-6.
-
(2004)
Arq Gastroenterol
, vol.41
, pp. 71-76
-
-
Lgv, C.1
Mattos, A.A.2
Cfm, F.3
-
14
-
-
12244295761
-
Low Helicobacter pylori eradication rates with 4-and 7-day regimens in an Iranian population
-
Malekzadeh R, Merat S, Derakhshan MH, et al. Low Helicobacter pylori eradication rates with 4-and 7-day regimens in an Iranian population. J Gastroenterol Hepatol 2003;18:13-7.
-
(2003)
J Gastroenterol Hepatol
, vol.18
, pp. 13-17
-
-
Malekzadeh, R.1
Merat, S.2
Derakhshan, M.H.3
-
15
-
-
60749100786
-
Cumulative H. pylori eradication rates in clinical practice by adopting first and second-line regimens proposed by the Maastricht III consensus and a third-line empirical regimen
-
Rokkas T, Sechopoulos P, Robotis I, et al. Cumulative H. pylori eradication rates in clinical practice by adopting first and second-line regimens proposed by the Maastricht III consensus and a third-line empirical regimen. Am J Gastroenterol 2009;104:21-5.
-
(2009)
Am J Gastroenterol
, vol.104
, pp. 21-25
-
-
Rokkas, T.1
Sechopoulos, P.2
Robotis, I.3
-
16
-
-
0033788930
-
Proton pump inhibitor, clarithromycin and either amoxicillin or nitroimidazole: A metanalysis of eradication of Helicobacter pylori
-
Gisbert JP, Gonzales L, Calvet X, et al. Proton pump inhibitor, clarithromycin and either amoxicillin or nitroimidazole: a metanalysis of eradication of Helicobacter pylori. Aliment Pharmacol Ther 2000;14:1319-28.
-
(2000)
Aliment Pharmacol Ther
, vol.14
, pp. 1319-1328
-
-
Gisbert, J.P.1
Gonzales, L.2
Calvet, X.3
-
18
-
-
0025162303
-
In vitro activity of azithromycin against various gram-negative bacilli and anaerobic bacteria
-
Kitzis MD, Goldstein FW, Miégi M, Acar JF. In vitro activity of azithromycin against various gram-negative bacilli and anaerobic bacteria. J Antimicrob Chemother 1990;25 Suppl A:15-18.
-
(1990)
J Antimicrob Chemother
, vol.25
, Issue.SUPPL. A
, pp. 15-18
-
-
Kitzis, M.D.1
Goldstein, F.W.2
Miégi, M.3
Acar, J.F.4
-
20
-
-
23744506840
-
Helicobacter pylori eradication using tetracycline and furazolidone versus amoxicillin and azithromycin in lansoprazole based triple therapy: An open randomized clinical trial
-
Frota LC, da Cunha Mdo P, Luz CR, de Araujo-Filho AH. Helicobacter pylori eradication using tetracycline and furazolidone versus amoxicillin and azithromycin in lansoprazole based triple therapy: an open randomized clinical trial. Arq Gastroenterol 2005;42:111-5.
-
(2005)
Arq Gastroenterol
, vol.42
, pp. 111-115
-
-
Frota, L.C.1
Da Cunha Mdo, P.2
Luz, C.R.3
De Araujo-Filho, A.H.4
-
21
-
-
0036791611
-
Azithromycin in a triple therapy for H. pylori eradication in active duodenal ulcer
-
Ivashkin VT, Lapina TL, Bondarenko OY, et al. Azithromycin in a triple therapy for H. pylori eradication in active duodenal ulcer. World J Gastroenterol 2002;8:879-92.
-
(2002)
World J Gastroenterol
, vol.8
, pp. 879-892
-
-
Ivashkin, V.T.1
Lapina, T.L.2
Bondarenko, O.Y.3
-
22
-
-
0030223132
-
Eradication of Helicobacter pylori using one week triple therapies combining omeprazole with two antimicrobials
-
Lind T, Veldhuyzen Van Zenten S, Unge P, et al. Eradication of Helicobacter pylori using one week triple therapies combining omeprazole with two antimicrobials. The MACH 1 study. Helicobacter 1996;1:138-44.
-
(1996)
The MACH 1 Study. Helicobacter
, vol.1
, pp. 138-144
-
-
Lind, T.1
Veldhuyzen Van Zenten, S.2
Unge, P.3
-
23
-
-
0032990642
-
Helicobacter pylori eradication with proton pump inhibitor-based triple therapies and re-treatment with ranitidine bismuth citratebased triple therapy
-
Rinaldi V, Zullo A, De Francesco V, et al. Helicobacter pylori eradication with proton pump inhibitor-based triple therapies and re-treatment with ranitidine bismuth citratebased triple therapy. Aliment Pharmacol Ther 1999;13: 163-8.
-
(1999)
Aliment Pharmacol Ther
, vol.13
, pp. 163-168
-
-
Rinaldi, V.1
Zullo, A.2
De Francesco, V.3
-
24
-
-
0007522959
-
The MACH 2 study: Eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy
-
Veldhuyzen Van Zanten SJO, Bradette M, Farley A, et al. The MACH 2 study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy. Aliment Pharmacol Ther 1999;13:289-95.
-
(1999)
Aliment Pharmacol Ther
, vol.13
, pp. 289-295
-
-
Van Zanten Sjo, V.1
Bradette, M.2
Farley, A.3
-
26
-
-
68849113749
-
Triple or quadruple tetracycline-based therapies versus standard triple treatment for Helicobacter pylori treatment
-
Songür Y, fienol A, Balkarli A, et al. Triple or quadruple tetracycline-based therapies versus standard triple treatment for Helicobacter pylori treatment. Am J Med Sci 2009; 338:50-3.
-
(2009)
Am J Med Sci
, vol.338
, pp. 50-53
-
-
Songür, Y.1
Fienol, A.2
Balkarli, A.3
-
27
-
-
0036534963
-
Management of Helicobacter pylori infection
-
Meurer LN, Bower DJ. Management of Helicobacter pylori infection. Am Fam Physician 2002;65:1327-36.
-
(2002)
Am Fam Physician
, vol.65
, pp. 1327-1336
-
-
Meurer, L.N.1
Bower, D.J.2
-
28
-
-
0141676717
-
One-day quadruple therapy compared with 7-day triple therapy for Helicobacter pylori infection
-
Lara LF, Cisneros G, Gurney M, et al. One-day quadruple therapy compared with 7-day triple therapy for Helicobacter pylori infection. Arch Intern Med 2003;163:2079-84.
-
(2003)
Arch Intern Med
, vol.163
, pp. 2079-2084
-
-
Lara, L.F.1
Cisneros, G.2
Gurney, M.3
-
29
-
-
0037185531
-
Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: A randomized controlled trial (MACLOR study)
-
Treiber G, Wittig J, Ammon S, et al. Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study). Arch Intern Med 2002;162:153-60.
-
(2002)
Arch Intern Med
, vol.162
, pp. 153-160
-
-
Treiber, G.1
Wittig, J.2
Ammon, S.3
-
30
-
-
0029942448
-
In-vitro active of azitromycin against intracellular Helicobacter pylori
-
Hulten K, Cars O, Hjelm E, Engstrand L. In-vitro active of azitromycin against intracellular Helicobacter pylori. J Antimicrob Chemother 1996;37:483-9.
-
(1996)
J Antimicrob Chemother
, vol.37
, pp. 483-489
-
-
Hulten, K.1
Cars, O.2
Hjelm, E.3
Engstrand, L.4
-
31
-
-
0031673838
-
Low-versus high-dose azithromycin triple therapy for Helicobacter pylori infection
-
Chey WD, Fisher L, Barnett J, et al. Low-versus high-dose azithromycin triple therapy for Helicobacter pylori infection. Aliment Pharmacol Ther 1998;12:1263-7.
-
(1998)
Aliment Pharmacol Ther
, vol.12
, pp. 1263-1267
-
-
Chey, W.D.1
Fisher, L.2
Barnett, J.3
-
32
-
-
0028900902
-
Azithromycin triple therapy for Helicobacter pylori infection: Azithromycin, tetracycline, and bismuth
-
al-Assi MT, Genta RM, Karttunen TJ, et al. Azithromycin triple therapy for Helicobacter pylori infection: azithromycin, tetracycline, and bismuth. Am J Gastroenterol 1995; 90:403-5.
-
(1995)
Am J Gastroenterol
, vol.90
, pp. 403-405
-
-
Al-Assi, M.T.1
Genta, R.M.2
Karttunen, T.J.3
-
33
-
-
0030027591
-
Triple therapy with azithromycin, omeprazole, and amoxicillin is highly effective in the eradication of Helicobacter pylori: A controlled trial versus omeprazole plus amoxicillin
-
Bertoni G, Sassatelli R, Nigrisoli E, et al. Triple therapy with azithromycin, omeprazole, and amoxicillin is highly effective in the eradication of Helicobacter pylori: a controlled trial versus omeprazole plus amoxicillin. Am J Gastroenterol 1996;91:258-63
-
(1996)
Am J Gastroenterol
, vol.91
, pp. 258-263
-
-
Bertoni, G.1
Sassatelli, R.2
Nigrisoli, E.3
-
34
-
-
33645194533
-
Azithromycin, furazolidone and omeprazole: A promising low-dose, low-cost, short-term anti H. pylori triple therapy [abstract]
-
Coelho LGV, Vieira WLS, Passos MCF. Azithromycin, furazolidone and omeprazole: a promising low-dose, low-cost, short-term anti H. pylori triple therapy [abstract]. Gastroenterology 1998;1196:296.
-
(1998)
Gastroenterology
, vol.1196
, pp. 296
-
-
Lgv, C.1
Wls, V.2
McF, P.3
-
35
-
-
0033000867
-
Furazolidone-containing short-term triple therapies are effective in the treatment of Helicobacter pylori infection
-
Liu WZ, Xiao, SD, Shi Y, et al. Furazolidone-containing short-term triple therapies are effective in the treatment of Helicobacter pylori infection. Aliment Pharmacol Ther 1999:13:317-22.
-
(1999)
Aliment Pharmacol Ther
, vol.13
, pp. 317-322
-
-
Liu, W.Z.1
Xiao, S.D.2
Shi, Y.3
-
36
-
-
0034094599
-
A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxicillin for treating Helicobacter pylori infection
-
Calvet X, Garcia N, Lopez T, et al. A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxicillin for treating Helicobacter pylori infection. Aliment Pharmacol Ther 2000;14:603-9.
-
(2000)
Aliment Pharmacol Ther
, vol.14
, pp. 603-609
-
-
Calvet, X.1
Garcia, N.2
Lopez, T.3
-
37
-
-
2442715467
-
Clinical effectiveness of omeprazole, azithromycin and amoxicillin in ulcer healing and eradication of Helicobacter pylori infection
-
Gribajceviæ M, Vanis N, Mesihoviæ R. Clinical effectiveness of omeprazole, azithromycin and amoxicillin in ulcer healing and eradication of Helicobacter pylori infection. Med Arh 2003;57:107-10.
-
(2003)
Med Arh
, vol.57
, pp. 107-110
-
-
Gribajceviæ, M.1
Vanis, N.2
Mesihoviæ, R.3
-
38
-
-
0032033978
-
A four-day low dose triple therapy regimen for the treatment of Helicobacter pylori infection
-
Trevisani L, Sartori S, Caselli M, et al. A four-day low dose triple therapy regimen for the treatment of Helicobacter pylori infection. Am J Gastroenterol 1998;93:390-3.
-
(1998)
Am J Gastroenterol
, vol.93
, pp. 390-393
-
-
Trevisani, L.1
Sartori, S.2
Caselli, M.3
-
39
-
-
0029850831
-
Helicobacter pylori eradication using one-week low-dose lansoprazole plus amoxycillin and either clarithromycin or azithromycin
-
Cammarota G, Tursi A, Papa A, et al. Helicobacter pylori eradication using one-week low-dose lansoprazole plus amoxycillin and either clarithromycin or azithromycin. Aliment Pharmacol Ther 1996;10:997-1000.
-
(1996)
Aliment Pharmacol Ther
, vol.10
, pp. 997-1000
-
-
Cammarota, G.1
Tursi, A.2
Papa, A.3
-
40
-
-
0033977723
-
Pantoprazole, amoxycillin and either azithromycin or clarithromycin for eradication of Helicobacter pylori in duodenal ulcer
-
Vcev A, Stimac D, Ivandic A, et al. Pantoprazole, amoxycillin and either azithromycin or clarithromycin for eradication of Helicobacter pylori in duodenal ulcer. Aliment Pharmacol Ther 2000;14:69-72.
-
(2000)
Aliment Pharmacol Ther
, vol.14
, pp. 69-72
-
-
Vcev, A.1
Stimac, D.2
Ivandic, A.3
-
41
-
-
33748448010
-
Levofloxacin-azithromycin combined triple therapy for Helicobacter pylori eradication
-
Kang MS, Park DI, Yun JW, et al. Levofloxacin-azithromycin combined triple therapy for Helicobacter pylori eradication. Korean J Gastroenterol 2006;47:30-6.
-
(2006)
Korean J Gastroenterol
, vol.47
, pp. 30-36
-
-
Kang, M.S.1
Park, D.I.2
Yun, J.W.3
|